These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17270148)

  • 21. The dual effects of leptin on aortic rings with and without endothelium isolated from streptozotocin-induced diabetic rats.
    Sahin AS; Bariskaner H; Gökbel H; Okudan N
    Methods Find Exp Clin Pharmacol; 2009 Jun; 31(5):325-9. PubMed ID: 19649339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
    Nagareddy PR; McNeill JH; MacLeod KM
    Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
    Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of improved glycaemic control with chlorpropamide on microvascular reactivity and nitric oxide synthase activity in diabetic rats.
    Sartoretto JL; Santos RA; Scavone C; Tostes RC; Nigro D; Carvalho MH; Cuman RK; Fortes ZB
    J Pharm Pharmacol; 2007 Aug; 59(8):1117-23. PubMed ID: 17725854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
    Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta.
    Woodman OL; Malakul W
    Life Sci; 2009 Jul; 85(1-2):54-9. PubMed ID: 19409910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
    Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
    Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression.
    Sartoretto JL; Melo GA; Carvalho MH; Nigro D; Passaglia RT; Scavone C; Cuman RK; Fortes ZB
    Life Sci; 2005 Oct; 77(21):2676-89. PubMed ID: 15964597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
    Neto-Ferreira R; Novaes Rocha V; da Silva Torres T; Mandarim-de-Lacerda CA; de Carvalho JJ
    Exp Toxicol Pathol; 2011 Jul; 63(5):473-8. PubMed ID: 20537513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A; Karasu C; Aktan F; Ozansoy G
    Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
    van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
    Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.
    Miersch S; Sliskovic I; Raturi A; Mutus B
    Free Radic Biol Med; 2007 Jan; 42(2):270-9. PubMed ID: 17189832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.
    Heidarianpour A; Hajizadeh S; Khoshbaten A; Niaki AG; Bigdili MR; Pourkhalili K
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):746-52. PubMed ID: 18043294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.
    López-Canales JS; López-Sanchez P; Perez-Alvarez VM; Wens-Flores I; Polanco AC; Castillo-Henkel E; Castillo-Henkel C
    Braz J Med Biol Res; 2011 May; 44(5):438-44. PubMed ID: 21445535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of K+ channels in the endothelium-dependent and endothelium-independent components of the relaxant effect of rosuvastatin in rat aortic rings.
    López J; Mendoza R; Cleva Villanueva G; Martínez G; Castillo EF; Castillo C
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):207-13. PubMed ID: 18635753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.
    Brunetti ND; Maulucci G; Casavecchia GP; Distaso C; De Gennaro L; Pellegrino PL; Di Biase M
    J Interv Cardiol; 2007 Dec; 20(6):481-7. PubMed ID: 18042053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.